Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00083525
Status:
COMPLETED
Last Update Posted:
2008-01-24
First Post:
2004-05-25
Brief Title:
Urokinase-Plasminogen Activator uPA Inhibitor WX-UK1 in Combination With Capecitabine in Advanced Malignancies
Sponsor:
Heidelberg Pharma AG
Organization:
Heidelberg Pharma AG
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-05
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2004-05-25
First Submit QC Date:
May 25 2004
Study First Post Date:
2004-05-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-01-21
Last Update Post Date:
2008-01-24
Last Update Post Date Type:
ESTIMATED